Safety and efficacy of amiselimod in relapsing multiple sclerosis (MOMENTUM): a randomised, double-blind, placebo-controlled phase 2 trial
Titel:
Safety and efficacy of amiselimod in relapsing multiple sclerosis (MOMENTUM): a randomised, double-blind, placebo-controlled phase 2 trial
Auteur:
Kappos, Ludwig Arnold, Douglas L Bar-Or, Amit Camm, John Derfuss, Tobias Kieseier, Bernd C Sprenger, Till Greenough, Kristin Ni, Pingping Harada, Tomohiko